AbbVie Enters Into the Obesity Drug Market With a License Agreement
GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.
Category: Anti-obesity Drugs
GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.
